アメナメビル
↑ Kato K.,et al., Clin.Pharmacol.Drug Dev., 8 (5), 595-602, (2019)
↑ Kawashima M, and others. (November 2017). “Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study”. The Journal of Dermatology 44 (11): 1219–1227. doi:10.1111/1346-8138.13948. PMC 5697646. PMID 28681394. https://www.ncbi.nlm.nih.
帯状疱疹
再発性の単純疱疹